Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record.

Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland

Open access
Lynn, Richard M., O'Brien, Sarah J., Taylor, C. Mark, Adak, Goutam K., Chart, Henrik, Cheasty, Tom, Coia, John E., Gillespie, Iain A., Locking, Mary E., Reilly, William J., Smith, Henry R., Waters, Aoife, Willshaw, Geraldine A. · 2005 · Emerging Infectious Diseases

Abstract

We conducted prospective surveillance of childhood hemolytic uremic syndrome (HUS) from 1997 to 2001 to describe disease incidence and clinical, epidemiologic and microbiologic characteristics.We compared our findings, where possible, with those of a previous study conducted from 1985 to 1988.The average annual incidence of HUS for the United Kingdom and Ireland (0.71/100,000) was unchanged from 1985 to 1988.The overall early mortality had halved, but the reduction in mortality was almost entirely accounted for by improved outcome in patients with diarrhea-associated HUS.The principal infective cause of diarrhea-associated HUS was Shiga toxin-producing Escherichia coli O157 (STEC O157), although in the 1997-2001 survey STEC O157 phage type (PT) 21/28 had replaced STEC O157 PT2 as the predominant PT.The risk of developing diarrhea-associated HUS was significantly higher in children infected with STEC O157 PT 2 and PT 21/28 compared with other PTs.Hypertension as a complication of HUS was greatly reduced in patients with diarrhea-associated HUS.T he most serious manifestation of infection with Shiga toxin-producing Escherichia coli (STEC) in humans is hemolytic uremic syndrome (HUS).This syndrome comprises a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure, usually after a prodromal illness of acute gastroenteritis (1).At least 80% of childhood HUS is attributable to infection with STEC (2), mainly serogroup O157, although other serogroups are implicated (2-10).The peak incidence of HUS is in children <5 years of age (1).Surveillance of pediatric HUS provides valuable information on human infection with STEC.In a prospective survey of pediatric HUS from 1985 to 1988 in the British Isles, the average annual incidence was ≈0.79 per 100,000 children <16 years of age (3).In the intervening years, the number of laboratory-confirmed cases of STEC O157 in England and Wales increased from 50 in 1985 (11) to 1,087 in 1997 (12).Similar increases were seen in Scotland and Ireland (Figure).Some of the increase in STEC O157 might reflect improved laboratory techniques, improved detection or reporting of milder cases, and a greater awareness of the need to investigate diarrheal disease for STEC.If the increase in STEC O157 was real, however, then the incidence of childhood HUS should have also increased.Therefore, we conducted prospective surveillance of childhood HUS in the United Kingdom and Ireland from 1997 to 2001 to describe the impact of disease and clinical, epidemiologic, and microbiologic characteristics of the patients.We also compared our findings, where possible, with those of a previous study (3,4). Patients and Methods Definition of HUSHUS was defined as 1) acute renal failure, including oligoanuria and elevated creatinine level for age, 2) microangiopathic hemolytic anemia (hemoglobin level <10 g/L with fragmented erythrocytes), and 3) thrombocy- Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1104.040833

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 199

Metadata

Authors
Lynn, R. M., O'Brien, S. J., Taylor, C. M., Adak, G. K., Chart, H., Cheasty, T., Coia, J. E., Gillespie, I. A., Locking, M. E., Reilly, W. J., Smith, H. R., Waters, A., & Willshaw, G. A.
Venue
Emerging Infectious Diseases
Published
2005-04
Volume
11
Issue
4
Pages
590-596
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2024243377
Cited by
199
References
0
FWCI
3.22
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland. https://app.cochat.ai/papers/10.3201/eid1104.040833
The paper
Lynn, R. M., O'Brien, S. J., Taylor, C. M., Adak, G. K., Chart, H., Cheasty, T., Coia, J. E., Gillespie, I. A., Locking, M. E., Reilly, W. J., Smith, H. R., Waters, A., & Willshaw, G. A. (2005). Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland. Emerging Infectious Diseases. https://doi.org/10.3201/eid1104.040833

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.